Clinical trial
Allogeneic Bone Marrow Transplantation in Patients With Primary…
NCT00006054 · Fairview University Medical Center, Other · Terminated
Key facts
| NCT number | NCT00006054 |
|---|---|
| Title | Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies |
| Lead sponsor | Fairview University Medical Center, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome, Common Variable Immunodeficiency, Graft Versus Host Disease, X-Linked Lymphoproliferative Syndrome, Familial Erythrophagocytic Lymphohistiocytosis, Hemophagocytic Lymphohistiocytosis, X-linked Agammaglobulinemia, Wiskott-Aldrich Syndrome, Chronic Granulomatous Disease and 4 more |
| Intervention type | Drug, Procedure |
| Interventions | anti-thymocyte globulin, busulfan, cyclophosphamide, cyclosporine, etoposide, methotrexate, methylprednisolone, prednisone, Allogeneic Bone Marrow Transplantation |
| Start date | Mar 1, 2000 |
| Primary completion | Dec 1, 2002 |
| Completion | Dec 1, 2002 |
| First posted | Jul 6, 2000 |
| Last update posted | Oct 15, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: